WOLLENBERG, A.; CORK, M.; FLOHR, C.; BEWLEY, A.; BLAUVELT, A.; HONG, C.- ho; IMAFUKU, S.; SCHUTTELAAR, M. L.; SIMPSON, E.; SOONG, W.; AMOUDRUZ, P.; WENDICKE LOPHAVEN, K. .; KURBASIC, A.; SOLDBRO, L.; STRANGE VEST, N. .; PALLER, A. Safety of tralokinumab in pediatric patients aged 12-17 years with moderate to severe atopic dermatitis: results from the phase 3 ECZTRA 6 trial. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 2, p. s140, 2023. DOI: 10.25251/skin.7.supp.140. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/2029. Acesso em: 4 jul. 2024.